Evolucin de los tratamientos dirigidos al receptor GLP-1, desde formulaciones inyectables hasta la nueva generacin oral
I use my clinical judgment and sometimes do not adhere to the guidelines, but consider other aspects
doi: 10.3390/brainsci13111503 [DOI] [PMC free article] [PubMed] [Google Scholar] 24.Weiss EP, Jordan RC, Frese EM, Albert SG, Villareal DT
Antioxidant Blend: Aqua Skin Veniscy 368 Glutathione Injections are enriched with a blend of natural antioxidants
Supplies Needed Estimated requirements based on an 816 week protocol at 2 mg daily dosage : Tesamorelin 10 mg Vials 8 weeks: ~11 vials 12 weeks: ~17 vials 16 weeks: ~22 vials Insulin Syringes (U-100) 1 per day 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL Bottles) ~3.0 mL per vial 8 weeks: ~4 bottles 12 weeks: ~6 bottles 16 weeks: ~7 bottles Alcohol Swabs 2 per day (vial + injection site) 8 weeks: ~112 swabs 12 weeks: ~168 swabs 16 weeks: ~224 swabs Protocol Overview A simplified overview of the daily regimen: Goal: Reduce visceral fat and improve metabolic health Schedule: Daily injections for 1226 weeks Dosage: 2 mg daily after initial titration Reconstitution: 3.0 mL per vial Storage: Refrigerate
Natural approaches that stimulate endogenous GLP-1 release produce transient elevations in GLP-1 levels that are quickly degraded by DPP-4 enzymes
